Urocortin dosing & administration
A powerful stress-response peptide that protects your heart and helps your body handle pressure
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Intravenous infusion: Delivered straight into a vein through a drip (IV), done by a clinician.
Bioavailability Complete (about 100%) — delivered straight into the bloodstream.
2 documented dose levels — separate regimens, not a titration schedule
5 ng/kg/min (urocortin-2)
Frequency
Continuous infusion
Duration
4 hours
Adjunct dose used in the UNICORN study of 53 acute decompensated heart failure patients [6]. Investigational only.
Urocortin-2 36–360 pmol/min or urocortin-3 1.2–12 nmol/min (ascending)
Frequency
Incremental infusion
Duration
Per study protocol
Ascending IV doses studied in chronic heart failure patients; increased cardiac index and reduced vascular resistance [7]. Research use only — no approved product.
Timing
Best time to take
Use Urocortin at the same time each day for optimal results. Consistency in timing helps maintain stable levels and maximize therapeutic benefits. Follow your healthcare provider's specific instructions.
With food?
Urocortin can generally be used with or without food. If you experience any discomfort, try taking it with a light meal. Follow specific guidance from your healthcare provider.
If stacking
Urocortin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Urocortin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Urocortin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: As directed by healthcare provider—rotate sites if applicable
Maintain a consistent schedule for optimal results with Urocortin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Facial flushing, Mild headache, Dizziness, Injection site response, Nausea
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Urocortin
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Urocortin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Certain blood pressure medications (may cause excessive drops - requires medical adjustment) — Use with caution—discuss with your healthcare provider.
- Strong CRF antagonists (may counteract urocortin effects) — Use with caution—discuss with your healthcare provider.
- Anesthetics (may interact - requires medical oversight) — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Takefuji M, Murohara T · 2019
Urocortin-2 and related CRF peptides activate heart-specific receptors (CRHR2) to improve cardiac pumping ability through cAMP signaling pathways. Recent clinical trials identified CRHR2 as a promising therapeutic target for heart failure treatment, with the heart being a major site where these peptides protect cardiovascular function.
Chatzaki E, Kefala N, Drosos I · 2019
Urocortins show significant therapeutic potential for multiple cardiovascular diseases including congestive heart failure, ischemic heart disease, and hypertension. Clinical trials testing urocortins for diagnosis and treatment of cardiovascular disease produced encouraging results, establishing their role as emerging therapies for heart disease management.
Giamouridis D, Gao MH, Lai NC · 2018
Gene transfer of urocortin-2 improved both systolic and diastolic heart function while also improving glucose metabolism and control in heart failure patients. Urocortin-2 showed superior metabolic benefits compared to urocortin-3, suggesting it may be optimal for patients with combined diabetes and heart failure.
Adão R, Mendes-Ferreira P, Santos-Ribeiro D · 2018
Urocortin-2 specifically strengthens the right heart's pumping ability while reducing pulmonary hypertension severity through improved vascular function. This peptide shows promise as a targeted therapy for conditions affecting the right side of the heart and lung blood vessels, where traditional heart failure treatments often fall short.
Rademaker MT, Richards AM · 2017
Urocortins act as natural protective molecules in healthy hearts and show significant therapeutic potential in heart failure through multiple mechanisms including improved heart contractions and stress adaptation. These peptides also serve as useful biomarkers for assessing cardiac disease severity and may guide personalized treatment strategies.
Chan WYW, Frampton CM, Crozier IG, Troughton RW, Richards AM · 2013
Stirrat CG, Venkatasubramanian S, Pawade T, et al. · 2016
Head to head
Urocortin compared
Want the full picture?
The complete Urocortin research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.